Global Pancreatic Stents Market Insights and Forecast to 2028

Pancreatic endotherapy has been used progressively for the treatment of a range of pancreatic disorders such as drainage of pseudocysts, chronic pancreatitis, recurrent acute pancreatitis, or disruptions, pancreatic duct leaks, and for the prevention of pancreatitis post ERCP (endoscopic retrograde cholangiopancreatography). The most common type of pancreatic endotherapy used is pancreatic stenting.
Market Analysis and Insights: Global Pancreatic Stents Market
Due to the COVID-19 pandemic, the global Pancreatic Stents market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Straight Pancreatic Stents accounting for % of the Pancreatic Stents global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Pancreatic Stents market size is valued at US$ million in 2021, while the US and Europe Pancreatic Stents are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pancreatic Stents landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Pancreatic Stents include Boston Scientific Corporation, C. R. Bard, Merit Medical Systems, Inc., Cook Group Incorporated, Becton, Dickinson and Company, Cantel Medical Corporation, Olympus Corporation and ConMed Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pancreatic Stents Scope and Segment
Pancreatic Stents market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pancreatic Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Straight Pancreatic Stents
Wedge Pancreatic Stents
Curved Pancreatic Stents
Segment by Application
Hospitals
Clinics
Others
By Company
Boston Scientific Corporation
C. R. Bard
Merit Medical Systems, Inc.
Cook Group Incorporated
Becton
Dickinson and Company
Cantel Medical Corporation
Olympus Corporation
ConMed Corporation
ENDO-FLEX GmbH
Diagmed Healthcare Ltd.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions